# Adi Diab

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/adi-diab/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,713 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 64 |
| i10-index | 160 |
| Last Known Institution | Cleveland Clinic |
| OpenAlex ID | https://openalex.org/A5030834372 |
| ORCID iD | https://orcid.org/0000-0002-0153-0244 |
| Works | 459 |

## Researcher papers

- [Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma](https://scholariq.org/papers/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma/)
- [A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant](https://scholariq.org/papers/a-multi-center-study-on-safety-and-efficacy-of-immune-checkpoint-inhibitors-in/)
- [Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy](https://scholariq.org/papers/bempegaldesleukin-selectively-depletes-intratumoral-tregs-and-potentiates-t-cell/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Researcher university

- [Cleveland Clinic](https://scholariq.org/institutions/cleveland-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.